Special Interest Group
Lymphedema is a common side effect of cancer treatment impacting many survivors. The Lymphatic Diseases SIG serves to help disseminate information for physical therapists and physical therapist assistants working with patients with lymphedema, through related literature, updates on lymphedema legislation and shared information between therapists experienced in treating the condition. Our common purpose is to enhance the quality of life of patients with lymphedema that we treat.
The Mission of the Lymphatic Diseases SIG
The mission of Lymphatic Diseases SIG is to provide a forum to connect therapists who have a common interest in swelling disorders to network, stay up to date and share information to enhance and benefit the patients we serve.
SIG Member Resources
Lymphedema Event Calendar
APTA Oncology and the Lymphatic Diseases SIG hope to provide members with opportunities to advance skills, develop professional networks, and promote awareness of lymphedema and oncology rehab. Visit our Education page to check out our calendar of upcoming opportunities.
Lymphedema Research Collection
APTA Oncology’s official journal, Rehabilitation Oncology, has organized all articles related to lymphatic diseases into one convenient collection! Visit the collection to review state of the art literature in our field today. Please note, to access content as a member of APTA Oncology, please sign and access the journal via our ‘For Members‘ page, not under Publications.
Peter S. Mortimer and Stanley G. Rockson. New developments in clinical aspects of lymphatic disease . J Clin Invest. 2014 Mar 3; 124(3): 915–921. doi: 10.1172/JCI71608 PMCID: PMC3938261
“Arguably, it may be better to consider the presence of chronic edema as synonymous with the presence of lymphedema, inasmuch as all edema represents relative lymph drainage failure”
The lymphatic system is fundamentally important to cardiovascular disease, infection and immunity, cancer, and probably obesity — the four major challenges in healthcare in the 21st century. This Review will consider the manner in which new knowledge of lymphatic genes and molecular mechanisms has demonstrated that lymphatic dysfunction should no longer be considered a passive bystander in disease but rather an active player in many pathological processes and, therefore, a genuine target for future therapeutic developments. The specific roles of the lymphatic system in edema, genetic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn’s disease, obesity, cancer, and cancer-related lymphedema are highlighted.
Interested in joining an APTA Oncology Special Interest Group (SIG)?
APTA Oncology has several course offerings looking for partners to host. The host facility will be chosen based on the guarantee that they can draw a minimum of 15 registrants.
APTA Oncology's General Listerv is a very productive messaging system for answering your practice questions. In addition, we maintain specialized listservs for our special interest groups.
Any PT or PTA living in a country other than the US or a healthcare provider from another discipline, not eligible for APTA membership, can take advantage of our membership benefits by becoming a Partner of APTA Oncology.